BMND15
MCID: BNM029
MIFTS: 48

Bone Mineral Density Quantitative Trait Locus 15 (BMND15)

Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Bone Mineral Density Quantitative Trait Locus 15

MalaCards integrated aliases for Bone Mineral Density Quantitative Trait Locus 15:

Name: Bone Mineral Density Quantitative Trait Locus 15 56 6 39
Osteoporosis 56 71
Metaphyseal Fracture, Susceptibility to 56
Compression Fracture, Susceptibility to 56
Osteoporosis, Susceptibility to 56
Fractures, Compression 71
Metaphyseal Fractures 6
Metaphyseal Fracture 56
Compression Fracture 56
Bmnd15 56

Characteristics:

OMIM:

56
Inheritance:
autosomal recessive
autosomal dominant


HPO:

31
bone mineral density quantitative trait locus 15:
Inheritance autosomal dominant inheritance autosomal recessive inheritance


Classifications:



External Ids:

OMIM 56 613418
MedGen 41 C3150680
SNOMED-CT via HPO 68 258211005 263681008 64859006
UMLS 71 C0029456 C0521169

Summaries for Bone Mineral Density Quantitative Trait Locus 15

MalaCards based summary : Bone Mineral Density Quantitative Trait Locus 15, also known as osteoporosis, is related to osteoporosis and osteoporosis, juvenile, and has symptoms including tremor, back pain and angina pectoris. An important gene associated with Bone Mineral Density Quantitative Trait Locus 15 is MIR2861 (MicroRNA 2861). The drugs Linagliptin and Dinoprostone have been mentioned in the context of this disorder. Affiliated tissues include bone, breast and prostate, and related phenotype is osteoporosis.

More information from OMIM: 613418

Related Diseases for Bone Mineral Density Quantitative Trait Locus 15

Diseases in the Bone Mineral Density Quantitative Trait Locus 15 family:

Bone Mineral Density Quantitative Trait Locus 4 Bone Mineral Density Quantitative Trait Locus 18
Bone Mineral Density Quantitative Trait Locus 1 Bone Mineral Density Quantitative Trait Locus 2
Bone Mineral Density Quantitative Trait Locus 3 Bone Mineral Density Quantitative Trait Locus 5
Bone Mineral Density Quantitative Trait Locus 6 Bone Mineral Density Quantitative Trait Locus 7
Bone Mineral Density Quantitative Trait Locus 8 Bone Mineral Density Quantitative Trait Locus 9
Bone Mineral Density Quantitative Trait Locus 10 Bone Mineral Density Quantitative Trait Locus 11
Bone Mineral Density Quantitative Trait Locus 12 Bone Mineral Density Quantitative Trait Locus 13
Bone Mineral Density Quantitative Trait Locus 14 Bone Mineral Density Quantitative Trait Locus 16
Bone Mineral Density Quantitative Trait Locus 17

Diseases related to Bone Mineral Density Quantitative Trait Locus 15 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1098, show less)
# Related Disease Score Top Affiliating Genes
1 osteoporosis 33.2 PDLIM4 MIR2861 CALCR
2 osteoporosis, juvenile 12.9
3 osteoporosis-pseudoglioma syndrome 12.8
4 nephrolithiasis/osteoporosis, hypophosphatemic, 1 12.7
5 glucocorticoid-induced osteoporosis 12.6
6 juvenile primary osteoporosis 12.6
7 nephrolithiasis/osteoporosis, hypophosphatemic, 2 12.6
8 osteoporosis and oculocutaneous hypopigmentation syndrome 12.5
9 hypophosphatemic nephrolithiasis/osteoporosis 12.4
10 macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance 12.3
11 hajdu-cheney syndrome 12.3
12 growth failure, microcephaly, mental retardation, cataracts, large joint contractures, osteoporosis, cortical dysplasia, and cerebellar atrophy 12.2
13 dominant hypophosphatemia with nephrolithiasis or osteoporosis 12.2
14 bone mineral density quantitative trait locus 8 12.2
15 amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis, and acidosis 12.2
16 cutis laxa osteoporosis 12.1
17 osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome 12.1
18 lrp5-related primary osteoporosis 12.1
19 bone mineral density quantitative trait locus 18 12.0
20 bone mineral density quantitative trait locus 16 11.8
21 premature ovarian failure 1 11.7
22 werner syndrome 11.6
23 aromatase deficiency 11.6
24 bone disease 11.6
25 bone mineral density quantitative trait locus 12 11.6
26 rickets 11.6
27 syndromic x-linked intellectual disability snyder type 11.6
28 lysinuric protein intolerance 11.5
29 mental retardation, x-linked, syndromic, snyder-robinson type 11.5
30 geroderma osteodysplasticum 11.5
31 hyperparathyroidism 11.5
32 hypogonadotropic hypogonadism 11.5
33 premature aging syndrome, okamoto type 11.4
34 cerebrotendinous xanthomatosis 11.4
35 acth-secreting pituitary adenoma 11.4
36 cholangitis, primary sclerosing 11.4
37 spondyloocular syndrome 11.4
38 cleidocranial dysplasia 11.4
39 hyperthyroidism 11.4
40 anorexia nervosa 11.4
41 celiac disease 1 11.4
42 systemic mastocytosis 11.4
43 spondyloepimetaphyseal dysplasia, shohat type 11.3
44 eating disorder 11.3
45 osteopetrosis 11.3
46 multicentric osteolysis, nodulosis, and arthropathy 11.3
47 graves' disease 11.3
48 turner syndrome 11.3
49 severe congenital neutropenia 11.3
50 pituitary adenoma 4, acth-secreting 11.3
51 homocystinuria 11.3
52 calvarial doughnut lesions with bone fragility 11.3
53 exudative vitreoretinopathy 11.3
54 spinal disease 11.3
55 cleft palate, isolated 11.3
56 menkes disease 11.3
57 parathyroid carcinoma 11.3
58 dyskeratosis congenita 11.3
59 kallmann syndrome 11.3
60 winchester syndrome 11.3
61 bone resorption disease 11.2
62 epiphyseal dysplasia, multiple, with early-onset diabetes mellitus 11.2
63 mucolipidosis iii alpha/beta 11.2
64 nestor-guillermo progeria syndrome 11.2
65 csf1r-related brain malformation and osteopetrosis 11.1
66 hyperparathyroidism 1 11.1
67 dyskeratosis congenita, autosomal recessive 1 11.1
68 hyaline fibromatosis syndrome 11.1
69 mucolipidosis iii gamma 11.1
70 prader-willi habitus, osteopenia, and camptodactyly 11.1
71 osteogenesis imperfecta, type xii 11.1
72 dyskeratosis congenita, autosomal dominant 2 11.1
73 osteogenesis imperfecta, type xiii 11.1
74 dyskeratosis congenita, autosomal recessive 5 11.1
75 pigmented nodular adrenocortical disease, primary, 4 11.1
76 dyskeratosis congenita, autosomal dominant 6 11.1
77 ehlers-danlos syndrome, classic-like, 2 11.1
78 singleton-merten syndrome 1 11.0
79 hyperparathyroidism 2 with jaw tumors 11.0
80 dyskeratosis congenita, autosomal dominant 1 11.0
81 aspartylglucosaminuria 11.0
82 cardiomyopathy, dilated, with hypergonadotropic hypogonadism 11.0
83 acth-independent macronodular adrenal hyperplasia 11.0
84 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 11.0
85 achalasia-addisonianism-alacrima syndrome 11.0
86 glycogen storage disease ia 11.0
87 growth hormone insensitivity with immunodeficiency 11.0
88 diarrhea 2, with microvillus atrophy 11.0
89 bruck syndrome 1 11.0
90 parana hard-skin syndrome 11.0
91 rothmund-thomson syndrome, type 2 11.0
92 spondyloepimetaphyseal dysplasia, sponastrime type 11.0
93 dyskeratosis congenita, x-linked 11.0
94 kallmann syndrome with spastic paraplegia 11.0
95 stuve-wiedemann syndrome 11.0
96 pigmented nodular adrenocortical disease, primary, 2 11.0
97 pigmented nodular adrenocortical disease, primary, 1 11.0
98 osteogenesis imperfecta, type viii 11.0
99 candidiasis, familial, 6 11.0
100 dyskeratosis congenita, autosomal recessive 2 11.0
101 dyskeratosis congenita, autosomal recessive 3 11.0
102 dyskeratosis congenita, autosomal dominant 3 11.0
103 pigmented nodular adrenocortical disease, primary, 3 11.0
104 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies 11.0
105 estrogen resistance 11.0
106 acth-independent macronodular adrenal hyperplasia 2 11.0
107 analbuminemia 11.0
108 dyskeratosis congenita, autosomal recessive 6 11.0
109 thrombocytopenia 6 11.0
110 ovarian dysgenesis 8 11.0
111 primary pigmented nodular adrenocortical disease 11.0
112 46,xy sex reversal 11.0
113 atypical werner syndrome 11.0
114 neonatal adrenoleukodystrophy 11.0
115 singleton-merten syndrome 11.0
116 idiopathic infantile hypercalcemia 11.0
117 bone mineral density quantitative trait locus 3 10.9
118 osteoarthritis 10.8
119 osteonecrosis 10.8
120 hypogonadism 10.8
121 osteomalacia 10.8
122 back pain 10.7
123 osteonecrosis of the jaw 10.7
124 rheumatoid arthritis 10.7
125 secondary hyperparathyroidism 10.6
126 triiodothyronine receptor auxiliary protein 10.6
127 arthritis 10.6
128 mammary paget's disease 10.6
129 brittle bone disorder 10.6
130 primary hyperparathyroidism 10.6
131 inflammatory bowel disease 10.6
132 diabetes mellitus 10.6
133 periodontitis 10.5
134 amenorrhea 10.5
135 body mass index quantitative trait locus 1 10.5
136 pulmonary disease, chronic obstructive 10.5
137 inflammatory spondylopathy 10.5
138 spondylitis 10.5
139 spondyloarthropathy 1 10.5
140 chronic kidney disease 10.5
141 thalassemia 10.5
142 spinal cord injury 10.5
143 insulin-like growth factor i 10.5
144 mastocytosis 10.4
145 liver disease 10.4
146 liver cirrhosis 10.4
147 aging 10.4
148 alcohol use disorder 10.4
149 prostate cancer 10.4
150 sclerosteosis 10.4
151 kidney disease 10.4
152 endometrial cancer 10.4
153 avascular necrosis 10.4
154 nephrolithiasis 10.4
155 primary biliary cirrhosis 10.4
156 chronic pain 10.4
157 autoimmune disease 10.4
158 alcohol dependence 10.4
159 crohn's disease 10.4
160 myeloma, multiple 10.4
161 atherosclerosis susceptibility 10.3
162 hypothyroidism 10.3
163 lipid metabolism disorder 10.3
164 arthropathy 10.3
165 body mass index quantitative trait locus 11 10.3
166 scoliosis 10.3
167 breast cancer 10.3
168 osteogenic sarcoma 10.3
169 body mass index quantitative trait locus 9 10.3
170 body mass index quantitative trait locus 8 10.3
171 body mass index quantitative trait locus 4 10.3
172 body mass index quantitative trait locus 10 10.3
173 body mass index quantitative trait locus 7 10.3
174 body mass index quantitative trait locus 12 10.3
175 body mass index quantitative trait locus 14 10.3
176 body mass index quantitative trait locus 18 10.3
177 body mass index quantitative trait locus 19 10.3
178 body mass index quantitative trait locus 20 10.3
179 lung disease 10.3
180 cystic fibrosis 10.3
181 paget's disease of bone 10.3
182 systemic lupus erythematosus 10.3
183 graves disease 1 10.3
184 beta-thalassemia 10.3
185 renal osteodystrophy 10.3
186 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.3
187 hemosiderosis 10.3
188 47,xyy 10.3
189 rare hereditary hemochromatosis 10.3
190 lupus erythematosus 10.3
191 yemenite deaf-blind hypopigmentation syndrome 10.2
192 plica syndrome 10.2
193 synovitis 10.2
194 hyperglycemia 10.2
195 coronary heart disease 1 10.2
196 endometrial hyperplasia 10.2
197 vascular disease 10.2
198 fibrosis of extraocular muscles, congenital, 1 10.2
199 paraplegia 10.2
200 connective tissue disease 10.2
201 temporal arteritis 10.2
202 endosteal hyperostosis, autosomal dominant 10.2
203 autosomal recessive disease 10.2
204 premature menopause 10.2
205 peptic ulcer disease 10.2
206 muscular dystrophy 10.2
207 rapidly involuting congenital hemangioma 10.2
208 urolithiasis 10.2
209 lactose intolerance 10.2
210 cholestasis 10.2
211 cerebral palsy 10.2
212 acromegaly 10.2
213 depression 10.2
214 spondylolisthesis 10.2
215 hyperprolactinemia 10.2
216 urticaria 10.2
217 enthesopathy 10.2
218 ulcerative colitis 10.2
219 hypercholesterolemia, familial, 1 10.2
220 acroosteolysis 10.2
221 hypogonadism, male 10.2
222 osteomyelitis 10.2
223 hypoparathyroidism 10.2
224 vitamin k deficiency bleeding 10.2
225 esophagitis 10.2
226 algoneurodystrophy 10.2
227 muscular atrophy 10.2
228 gastrointestinal system disease 10.2
229 pik3ca-related overgrowth syndrome 10.2
230 nephrolithiasis, calcium oxalate 10.2
231 reflex sympathetic dystrophy 10.2
232 leukemia, acute lymphoblastic 10.2
233 heart disease 10.2
234 hyperostosis 10.2
235 dermatitis 10.2
236 gastritis 10.2
237 juvenile rheumatoid arthritis 10.2
238 cataract 10.2
239 pemphigus 10.2
240 48,xyyy 10.2
241 thyroid carcinoma 10.2
242 psoriatic arthritis 10.1
243 dermatomyositis 10.1
244 benign paroxysmal positional nystagmus 10.1
245 spondylosis 10.1
246 bone inflammation disease 10.1
247 growth hormone deficiency 10.1
248 idiopathic hypercalciuria 10.1
249 multiple sclerosis 10.1
250 muscular dystrophy, duchenne type 10.1
251 constipation 10.1
252 arteriosclerosis 10.1
253 congestive heart failure 10.1
254 scleroderma, familial progressive 10.1
255 mastocytosis, cutaneous 10.1
256 gastroesophageal reflux 10.1
257 homocysteinemia 10.1
258 juvenile arthritis 10.1
259 deficiency anemia 10.1
260 hyperphosphatemia 10.1
261 hemiplegia 10.1
262 conn's syndrome 10.1
263 skin disease 10.1
264 myopathy 10.1
265 cerebrovascular disease 10.1
266 degenerative disc disease 10.1
267 alzheimer disease 10.1
268 periodontitis, chronic 10.1
269 hypophosphatemia 10.1
270 atrial fibrillation 10.1
271 uveitis 10.1
272 gout 10.1
273 impotence 10.1
274 ankylosis 10.1
275 cellulitis 10.1
276 pustulosis of palm and sole 10.1
277 adenoma 10.1
278 psoriasis 10.1
279 hypopituitarism 10.1
280 dysphagia 10.1
281 sarcoidosis 1 10.1
282 schizophrenia 10.1
283 esophageal cancer 10.1
284 hemochromatosis, type 1 10.1
285 asthma 10.1
286 stroke, ischemic 10.1
287 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
288 peripheral vascular disease 10.1
289 gingival recession 10.1
290 neutropenia 10.1
291 leukemia 10.1
292 nephrocalcinosis 10.1
293 diarrhea 10.1
294 renal tubular acidosis 10.1
295 hyperinsulinism 10.1
296 iron metabolism disease 10.1
297 complex regional pain syndrome 10.1
298 end stage renal disease 10.1
299 cholangitis 10.1
300 fatty liver disease 10.1
301 cytokine deficiency 10.1
302 colorectal cancer 10.0
303 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
304 helicobacter pylori infection 10.0
305 pitt-hopkins syndrome 10.0
306 gastric cancer 10.0
307 leukemia, acute lymphoblastic 3 10.0
308 metabolic acidosis 10.0
309 fibrous dysplasia 10.0
310 non-alcoholic fatty liver disease 10.0
311 hyperuricemia 10.0
312 dental caries 10.0
313 pulmonary fibrosis 10.0
314 bronchitis 10.0
315 spinal stenosis 10.0
316 vasculitis 10.0
317 bronchiectasis 10.0
318 hemophilia 10.0
319 arteries, anomalies of 10.0
320 hypoascorbemia 10.0
321 creatinine clearance quantitative trait locus 10.0
322 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.0
323 exanthem 10.0
324 sleep apnea 10.0
325 childhood acute lymphocytic leukemia 10.0
326 respiratory failure 10.0
327 nephrotic syndrome 10.0
328 dementia 10.0
329 gonadal dysgenesis 10.0
330 exostosis 10.0
331 osteitis fibrosa 10.0
332 rhinitis 10.0
333 indolent systemic mastocytosis 10.0
334 monoclonal gammopathy of uncertain significance 10.0
335 collagen disease 10.0
336 neurofibromatosis 10.0
337 premature aging 10.0
338 pemphigus vulgaris, familial 10.0
339 down syndrome 10.0
340 van buchem disease 10.0
341 spondylometaphyseal dysplasia, sedaghatian type 10.0
342 myasthenia gravis 10.0
343 alacrima, achalasia, and mental retardation syndrome 10.0
344 hyperlipoproteinemia, type iii 10.0
345 lipoprotein quantitative trait locus 10.0
346 colitis 10.0
347 idiopathic scoliosis 10.0
348 covid-19 10.0
349 siderosis 10.0
350 allergic hypersensitivity disease 10.0
351 goiter 10.0
352 ehlers-danlos syndrome 10.0
353 calcinosis 10.0
354 hepatitis c 10.0
355 endometriosis 10.0
356 systemic scleroderma 10.0
357 poliomyelitis 10.0
358 fibromyalgia 10.0
359 septic arthritis 10.0
360 cardiac arrest 10.0
361 acute cystitis 10.0
362 vertical talus, congenital 9.9
363 alkuraya-kucinskas syndrome 9.9
364 clubfoot 9.9
365 congenital amyoplasia 9.9
366 retinal detachment 9.9
367 diabetes mellitus, noninsulin-dependent 9.9
368 leprosy 3 9.9
369 proteasome-associated autoinflammatory syndrome 1 9.9
370 pycnodysostosis 9.9
371 bulimia nervosa 9.9
372 leukemia, chronic myeloid 9.9
373 myocardial infarction 9.9
374 hepatitis c virus 9.9
375 sexual disorder 9.9
376 estrogen-receptor positive breast cancer 9.9
377 spondyloarthropathy 9.9
378 polycystic ovary syndrome 9.9
379 iron deficiency anemia 9.9
380 thrombocytopenia 9.9
381 epilepsy 9.9
382 epidermolysis bullosa 9.9
383 plasmacytoma 9.9
384 pancreatitis 9.9
385 thyroid gland disease 9.9
386 intestinal disease 9.9
387 parathyroid adenoma 9.9
388 herpes zoster 9.9
389 neuropathy 9.9
390 pulmonary embolism 9.9
391 irritable bowel syndrome 9.9
392 alopecia 9.9
393 hypoglycemia 9.9
394 hansen's disease 9.9
395 polymyositis 9.9
396 differentiated thyroid carcinoma 9.9
397 scheuermann disease 9.9
398 pernicious anemia 9.9
399 osteogenesis imperfecta, type i 9.9
400 myositis 9.9
401 hypertriglyceridemia, familial 9.9
402 corneal dystrophy, epithelial basement membrane 9.9
403 hepatocellular carcinoma 9.9
404 trichorhinophalangeal syndrome, type i 9.9
405 lipoid congenital adrenal hyperplasia 9.9
406 hypophosphatemic rickets, x-linked recessive 9.9
407 pituitary adenoma, prolactin-secreting 9.9
408 xanthomatosis 9.9
409 dermatitis, atopic 9.9
410 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.9
411 microvascular complications of diabetes 3 9.9
412 microvascular complications of diabetes 4 9.9
413 microvascular complications of diabetes 6 9.9
414 microvascular complications of diabetes 7 9.9
415 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.9
416 peripheral artery disease 9.9
417 lymphoma 9.9
418 crohn's colitis 9.9
419 infant gynecomastia 9.9
420 otosclerosis 9.9
421 gynecomastia 9.9
422 peptic esophagitis 9.9
423 childhood type dermatomyositis 9.9
424 mental depression 9.9
425 hepatitis b 9.9
426 acute pancreatitis 9.9
427 substance abuse 9.9
428 acute kidney failure 9.9
429 gingivitis 9.9
430 skin carcinoma 9.9
431 radiculopathy 9.9
432 neuromuscular disease 9.9
433 hypokalemia 9.9
434 epidermolysis bullosa dystrophica 9.9
435 infertility 9.9
436 sleep disorder 9.9
437 peripheral nervous system disease 9.9
438 lymphopenia 9.9
439 bullous pemphigoid 9.9
440 pulmonary emphysema 9.9
441 hemophilic arthropathy 9.9
442 oncogenic osteomalacia 9.9
443 splenomegaly 9.9
444 brain injury 9.9
445 hypotonia 9.9
446 spasticity 9.9
447 systemic autoimmune disease 9.9
448 overgrowth syndrome 9.9
449 cauda equina syndrome 9.9
450 leiomyosarcoma 9.9
451 intestinal obstruction 9.9
452 ileus 9.9
453 al amyloidosis 9.9
454 mccune-albright syndrome 9.8
455 hutchinson-gilford progeria syndrome 9.8
456 pulmonary fibrosis, idiopathic 9.8
457 neural tube defects 9.8
458 spondylosis, cervical 9.8
459 thrombophilia due to thrombin defect 9.8
460 neurofibromatosis, type i 9.8
461 migraine with or without aura 1 9.8
462 bladder cancer 9.8
463 persistent hyperplastic primary vitreous, autosomal recessive 9.8
464 diabetes mellitus, type i 9.8
465 immune deficiency disease 9.8
466 mend syndrome 9.8
467 arts syndrome 9.8
468 rett syndrome 9.8
469 ataxia and polyneuropathy, adult-onset 9.8
470 allergic rhinitis 9.8
471 major depressive disorder 9.8
472 major affective disorder 8 9.8
473 major affective disorder 9 9.8
474 premature ovarian failure 7 9.8
475 fatty liver disease, nonalcoholic 1 9.8
476 anaplastic large cell lymphoma 9.8
477 non-alcoholic steatohepatitis 9.8
478 sensorineural hearing loss 9.8
479 nasopharyngitis 9.8
480 short bowel syndrome 9.8
481 microphthalmia 9.8
482 gastric ulcer 9.8
483 prostatic hypertrophy 9.8
484 quadriplegia 9.8
485 cardiovascular system disease 9.8
486 exocrine pancreatic insufficiency 9.8
487 sclerosing cholangitis 9.8
488 primary hypertrophic osteoarthropathy 9.8
489 candidiasis 9.8
490 bone cancer 9.8
491 viral hepatitis 9.8
492 autoimmune hepatitis 9.8
493 psychotic disorder 9.8
494 hemoglobinopathy 9.8
495 prostatic adenoma 9.8
496 adenocarcinoma 9.8
497 testicular cancer 9.8
498 interstitial lung disease 9.8
499 bipolar disorder 9.8
500 mood disorder 9.8
501 purpura 9.8
502 gastric adenocarcinoma 9.8
503 pituitary adenoma 9.8
504 milk allergy 9.8
505 adrenal adenoma 9.8
506 b-cell lymphoma 9.8
507 atrophic gastritis 9.8
508 amyloidosis 9.8
509 meningitis 9.8
510 hypervitaminosis d 9.8
511 col1a1/2 osteogenesis imperfecta 9.8
512 sickle cell disease 9.8
513 trichorhinophalangeal syndrome 9.8
514 aminoaciduria 9.8
515 distal renal tubular acidosis 9.8
516 ovarian epithelial cancer 9.8
517 age-related hearing loss 9.8
518 autonomic dysfunction 9.8
519 hypoxia 9.8
520 syncope 9.8
521 traumatic brain injury 9.8
522 inflammatory myopathy with abundant macrophages 9.8
523 vitreoretinopathy 9.8
524 polykaryocytosis inducer 9.7
525 prader-willi syndrome 9.7
526 scoliosis, isolated 1 9.7
527 ovarian cancer 9.7
528 marfan syndrome 9.7
529 inclusion body myositis 9.7
530 hypertension, essential 9.7
531 hyperostosis frontalis interna 9.7
532 hypercalcemia, infantile, 1 9.7
533 hypercalciuria, absorptive, 2 9.7
534 hernia, hiatus 9.7
535 hand skill, relative 9.7
536 exostoses, multiple, type i 9.7
537 multiple endocrine neoplasia, type i 9.7
538 angelman syndrome 9.7
539 amyotrophic lateral sclerosis 1 9.7
540 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.7
541 lung cancer 9.7
542 gaucher disease, type i 9.7
543 hypervitaminosis a 9.7
544 familial mediterranean fever 9.7
545 shwachman-diamond syndrome 1 9.7
546 pituitary hormone deficiency, combined, 2 9.7
547 sjogren syndrome 9.7
548 hypothyroidism, congenital, nongoitrous, 4 9.7
549 fabry disease 9.7
550 taqi polymorphism 9.7
551 prostatic hyperplasia, benign 9.7
552 macular degeneration, age-related, 1 9.7
553 sickle cell anemia 9.7
554 langerhans cell histiocytosis 9.7
555 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 9.7
556 huntington disease-like 2 9.7
557 prostate cancer, hereditary, 4 9.7
558 intraocular pressure quantitative trait locus 9.7
559 glass syndrome 9.7
560 lung cancer susceptibility 3 9.7
561 microvascular complications of diabetes 5 9.7
562 fanconi renotubular syndrome 2 9.7
563 microcephaly, epilepsy, and diabetes syndrome 9.7
564 graft-versus-host disease 9.7
565 bone mineral density quantitative trait locus 17 9.7
566 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.7
567 fetal akinesia deformation sequence 2 9.7
568 pulmonary hypertension 9.7
569 chlamydia pneumonia 9.7
570 brachydactyly 9.7
571 female breast cancer 9.7
572 vitamin b12 deficiency 9.7
573 progesterone-receptor positive breast cancer 9.7
574 pain agnosia 9.7
575 myelomeningocele 9.7
576 recessive dystrophic epidermolysis bullosa 9.7
577 stickler syndrome 9.7
578 silicosis 9.7
579 pre-eclampsia 9.7
580 glucose intolerance 9.7
581 fanconi syndrome 9.7
582 renal hypertension 9.7
583 portal hypertension 9.7
584 hydrocephalus 9.7
585 cholesteatoma of middle ear 9.7
586 ovarian disease 9.7
587 brucellosis 9.7
588 hydronephrosis 9.7
589 sarcoma 9.7
590 chlamydia 9.7
591 blind hypotensive eye 9.7
592 visual epilepsy 9.7
593 low compliance bladder 9.7
594 secondary hyperparathyroidism of renal origin 9.7
595 acute leukemia 9.7
596 guillain-barre syndrome 9.7
597 dental fluorosis 9.7
598 hypophosphatasia 9.7
599 adult-onset still's disease 9.7
600 46 xx gonadal dysgenesis 9.7
601 gingival disease 9.7
602 angioedema 9.7
603 ectropion 9.7
604 endogenous depression 9.7
605 lymphadenitis 9.7
606 pneumothorax 9.7
607 cystitis 9.7
608 ichthyosis 9.7
609 duodenal ulcer 9.7
610 neuritis 9.7
611 gaucher's disease 9.7
612 vaginitis 9.7
613 lateral sclerosis 9.7
614 hemangioma 9.7
615 glomerulonephritis 9.7
616 antiphospholipid syndrome 9.7
617 multiple endocrine neoplasia 9.7
618 lipomatosis 9.7
619 inappropriate adh syndrome 9.7
620 histiocytosis 9.7
621 mixed connective tissue disease 9.7
622 empty sella syndrome 9.7
623 anovulation 9.7
624 craniopharyngioma 9.7
625 thrombophlebitis 9.7
626 pseudohypoparathyroidism 9.7
627 glucose metabolism disease 9.7
628 spindle cell sarcoma 9.7
629 atrophic rhinitis 9.7
630 human immunodeficiency virus infectious disease 9.7
631 severe combined immunodeficiency 9.7
632 acquired immunodeficiency syndrome 9.7
633 inherited metabolic disorder 9.7
634 diffuse idiopathic skeletal hyperostosis 9.7
635 compartment syndrome 9.7
636 osteochondrosis 9.7
637 localized scleroderma 9.7
638 duodenitis 9.7
639 subacute delirium 9.7
640 myeloid leukemia 9.7
641 intermediate coronary syndrome 9.7
642 achalasia 9.7
643 postpartum depression 9.7
644 diabetic neuropathy 9.7
645 dystrophinopathies 9.7
646 chronic graft versus host disease 9.7
647 glioma 9.7
648 secondary adrenal insufficiency 9.7
649 skeletal dysplasias 9.7
650 spondylarthropathy 9.7
651 stevens-johnson syndrome/toxic epidermal necrolysis 9.7
652 tuberculous meningitis 9.7
653 pituitary tumors 9.7
654 postherpetic neuralgia 9.7
655 seizure disorder 9.7
656 glial tumor 9.7
657 progeroid syndrome 9.7
658 glomerular disease 9.7
659 undetermined colitis 9.7
660 thyroid cancer, nonmedullary, 2 9.7
661 lipomatosis, multiple 9.7
662 cystic angiomatosis of bone, diffuse 9.7
663 chondrosarcoma 9.7
664 polycythemia vera 9.7
665 retinoschisis 1, x-linked, juvenile 9.7
666 ventricular fibrillation, paroxysmal familial, 1 9.7
667 cyanosis, transient neonatal 9.7
668 aspiration pneumonia 9.7
669 mantle cell lymphoma 9.7
670 aphasia 9.7
671 pleomorphic lipoma 9.7
672 amnestic disorder 9.7
673 pulmonary edema 9.7
674 atrial heart septal defect 9.7
675 spondylolysis 9.7
676 tic disorder 9.7
677 neurilemmoma 9.7
678 temporal lobe epilepsy 9.7
679 intermittent claudication 9.7
680 pleural empyema 9.7
681 erdheim-chester disease 9.7
682 intracranial embolism 9.7
683 polycythemia 9.7
684 fibrous dysplasia/mccune-albright syndrome 9.7
685 bone marrow necrosis 9.7
686 dieterich's disease 9.7
687 lymphangiomatosis 9.7
688 rosai-dorfman disease 9.7
689 cerebral atrophy 9.7
690 head injury 9.7
691 b-cell non-hodgkin lymphoma 9.7
692 neurofibromatosis, type ii 9.6
693 pseudohypoparathyroidism, type ia 9.6
694 renal cell carcinoma, nonpapillary 9.6
695 multiple system atrophy 1 9.6
696 oculopharyngeal muscular dystrophy 9.6
697 otitis media 9.6
698 papillomatosis, confluent and reticulated 9.6
699 parkinson disease, late-onset 9.6
700 pheochromocytoma 9.6
701 pityriasis rubra pilaris 9.6
702 protoporphyria, erythropoietic, 1 9.6
703 protrusio acetabuli 9.6
704 pulmonary hypertension, primary, 1 9.6
705 dowling-degos disease 1 9.6
706 retinoblastoma 9.6
707 schistosoma mansoni infection, susceptibility/ 9.6
708 spondyloepimetaphyseal dysplasia, strudwick type 9.6
709 syringomyelia, noncommunicating isolated 9.6
710 thrombophilia due to activated protein c resistance 9.6
711 thyroid cancer, nonmedullary, 1 9.6
712 gnathodiaphyseal dysplasia 9.6
713 myelopathy, htlv-1-associated 9.6
714 facioscapulohumeral muscular dystrophy 1 9.6
715 moebius syndrome 9.6
716 lipomatosis, multiple symmetric 9.6
717 leukemia, chronic lymphocytic 9.6
718 jacobsen syndrome 9.6
719 hyper-ige recurrent infection syndrome 1, autosomal dominant 9.6
720 ichthyosis vulgaris 9.6
721 hypogonadotropic hypogonadism 7 with or without anosmia 9.6
722 hair whorl 9.6
723 fibrodysplasia ossificans progressiva 9.6
724 exudative vitreoretinopathy 1 9.6
725 exostoses, multiple, type ii 9.6
726 ehlers-danlos syndrome, classic type, 1 9.6
727 coloboma of macula 9.6
728 chiari malformation type i 9.6
729 leukocyte adhesion deficiency, type i 9.6
730 carpal tunnel syndrome 9.6
731 cardiac arrhythmia 9.6
732 arthrogryposis, distal, type 3 9.6
733 burkitt lymphoma 9.6
734 epidermolytic hyperkeratosis 9.6
735 tobacco addiction 9.6
736 trigeminal neuralgia 9.6
737 tuberous sclerosis 1 9.6
738 urate oxidase, pseudogene 9.6
739 varicose veins 9.6
740 vitreoretinopathy, neovascular inflammatory 9.6
741 von hippel-lindau syndrome 9.6
742 zinc finger protein 1 9.6
743 neuropathy, hereditary sensory and autonomic, type iia 9.6
744 arachnoid cysts, intracranial 9.6
745 arterial calcification, generalized, of infancy, 1 9.6
746 craniodiaphyseal dysplasia 9.6
747 neuropathy, hereditary sensory and autonomic, type iii 9.6
748 enterocolitis 9.6
749 galactorrhea 9.6
750 glycogen storage disease ii 9.6
751 renal glucosuria 9.6
752 ovarian dysgenesis 1 9.6
753 lymphoma, hodgkin, classic 9.6
754 hutterite cerebroosteonephrodysplasia syndrome 9.6
755 mckusick-kaufman syndrome 9.6
756 chylomicron retention disease 9.6
757 muscular dystrophy, limb-girdle, autosomal recessive 2 9.6
758 myelofibrosis 9.6
759 gyrate atrophy of choroid and retina 9.6
760 osteogenesis imperfecta, type iii 9.6
761 osteoid osteoma 9.6
762 osteopetrosis, autosomal recessive 1 9.6
763 pancreatic cancer 9.6
764 laron syndrome 9.6
765 taurodontism 9.6
766 mayer-rokitansky-kuster-hauser syndrome 9.6
767 spondylocostal dysostosis 1, autosomal recessive 9.6
768 xeroderma pigmentosum, variant type 9.6
769 alopecia, congenital 9.6
770 coats disease 9.6
771 hemophilia a 9.6
772 hemophilia b 9.6
773 lowe oculocerebrorenal syndrome 9.6
774 norrie disease 9.6
775 kearns-sayre syndrome 9.6
776 oncocytoma 9.6
777 gonadal agenesis 9.6
778 gallbladder disease 1 9.6
779 transsexuality 9.6
780 suppression of tumorigenicity 12 9.6
781 hypocalcemia, autosomal dominant 1 9.6
782 dental anomalies and short stature 9.6
783 dermatitis herpetiformis, familial 9.6
784 leukemia, acute myeloid 9.6
785 bone mineral density quantitative trait locus 1 9.6
786 hemochromatosis, type 2a 9.6
787 ossification of the posterior longitudinal ligament of spine 9.6
788 cervical cancer 9.6
789 chudley-mccullough syndrome 9.6
790 orthostatic intolerance 9.6
791 huntington disease-like 3 9.6
792 lymphoma, non-hodgkin, familial 9.6
793 paragangliomas 3 9.6
794 late-onset retinal degeneration 9.6
795 bone mineral density quantitative trait locus 2 9.6
796 genitopatellar syndrome 9.6
797 meningioma, radiation-induced 9.6
798 muscular dystrophy-dystroglycanopathy , type c, 5 9.6
799 meningioma, familial 9.6
800 epileptic encephalopathy, early infantile, 6 9.6
801 anxiety 9.6
802 carotid intimal medial thickness 2 9.6
803 severe cutaneous adverse reaction 9.6
804 leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 9.6
805 carney complex variant 9.6
806 aplastic anemia 9.6
807 mevalonic aciduria 9.6
808 asthma-related traits 4 9.6
809 osteogenesis imperfecta, type v 9.6
810 bone mineral density quantitative trait locus 7 9.6
811 hypophosphatemic rickets, autosomal recessive, 2 9.6
812 alpha-1-antitrypsin deficiency 9.6
813 complement component 3 deficiency, autosomal recessive 9.6
814 myelodysplastic syndrome 9.6
815 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.6
816 leptin deficiency or dysfunction 9.6
817 leptin receptor deficiency 9.6
818 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.6
819 osteogenesis imperfecta, type xv 9.6
820 seizures, scoliosis, and macrocephaly/microcephaly syndrome 9.6
821 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.6
822 hyperparathyroidism 4 9.6
823 helix syndrome 9.6
824 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.6
825 angina pectoris 9.6
826 tendinitis 9.6
827 tendinosis 9.6
828 kashin-beck disease 9.6
829 erythema multiforme 9.6
830 loeys-dietz syndrome 9.6
831 variola major 9.6
832 congenital generalized lipodystrophy 9.6
833 oculocutaneous albinism 9.6
834 arterial calcification of infancy 9.6
835 diffuse large b-cell lymphoma 9.6
836 paraganglioma 9.6
837 limb ischemia 9.6
838 colorectal adenoma 9.6
839 fibroma 9.6
840 follicular lymphoma 9.6
841 adrenal gland pheochromocytoma 9.6
842 autosomal recessive hypophosphatemic rickets 9.6
843 autism spectrum disorder 9.6
844 paraphilia disorder 9.6
845 brain meningioma 9.6
846 alexithymia 9.6
847 microscopic colitis 9.6
848 ileitis 9.6
849 persistent hyperplastic primary vitreous 9.6
850 parietal foramina 9.6
851 pollen allergy 9.6
852 drug allergy 9.6
853 autosomal recessive congenital ichthyosis 9.6
854 muscular disease 9.6
855 acromesomelic dysplasia 9.6
856 superior semicircular canal dehiscence 9.6
857 nodal marginal zone lymphoma 9.6
858 ankylosing spondylitis 1 9.6
859 isolated microphthalmia 9.6
860 bone sarcoma 9.6
861 aortic dissection 9.6
862 hemochromatosis type 2 9.6
863 corneal disease 9.6
864 dry eye syndrome 9.6
865 cholelithiasis 9.6
866 tuberculoid leprosy 9.6
867 pneumoconiosis 9.6
868 anthracosis 9.6
869 yaws 9.6
870 bacterial infectious disease 9.6
871 protein-losing enteropathy 9.6
872 open-angle glaucoma 9.6
873 chronic pyelonephritis 9.6
874 chronic frontal sinusitis 9.6
875 frontal sinusitis 9.6
876 lepromatous leprosy 9.6
877 microcephaly 9.6
878 transsexualism 9.6
879 intracranial aneurysm 9.6
880 discitis 9.6
881 pulpitis 9.6
882 allergic conjunctivitis 9.6
883 erysipelas 9.6
884 tetanus 9.6
885 bladder calculus 9.6
886 spinal meningioma 9.6
887 pyelonephritis 9.6
888 diphtheria 9.6
889 horner's syndrome 9.6
890 autonomic neuropathy 9.6
891 chondrocalcinosis 9.6
892 hyperandrogenism 9.6
893 palindromic rheumatism 9.6
894 protein-energy malnutrition 9.6
895 postmenopausal atrophic vaginitis 9.6
896 synostosis 9.6
897 neurogenic bladder 9.6
898 common variable immunodeficiency 9.6
899 oligohydramnios 9.6
900 cartilage disease 9.6
901 spinal muscular atrophy 9.6
902 tarsal tunnel syndrome 9.6
903 vestibular neuronitis 9.6
904 leiomyoma 9.6
905 sialolithiasis 9.6
906 scleritis 9.6
907 tuberous sclerosis 9.6
908 eclampsia 9.6
909 patent foramen ovale 9.6
910 sick sinus syndrome 9.6
911 polyneuropathy 9.6
912 schistosomiasis 9.6
913 iritis 9.6
914 toxic shock syndrome 9.6
915 frozen shoulder 9.6
916 ochronosis 9.6
917 shoulder impingement syndrome 9.6
918 labyrinthitis 9.6
919 cholera 9.6
920 avoidant personality disorder 9.6
921 personality disorder 9.6
922 normal pressure hydrocephalus 9.6
923 thrombocytopenia due to platelet alloimmunization 9.6
924 keratosis 9.6
925 ventricular septal defect 9.6
926 heart septal defect 9.6
927 neuroendocrine tumor 9.6
928 mitral valve stenosis 9.6
929 thyroid gland cancer 9.6
930 neuroma 9.6
931 encephalomalacia 9.6
932 post-traumatic stress disorder 9.6
933 hereditary multiple exostoses 9.6
934 essential thrombocythemia 9.6
935 myeloproliferative neoplasm 9.6
936 thrombocytosis 9.6
937 hepatitis 9.6
938 gastroenteritis 9.6
939 generalized atherosclerosis 9.6
940 hyperpituitarism 9.6
941 thrombophilia 9.6
942 basal cell carcinoma 9.6
943 orchitis 9.6
944 testicular disease 9.6
945 agammaglobulinemia 9.6
946 kidney cancer 9.6
947 myoma 9.6
948 bilirubin metabolic disorder 9.6
949 auditory system disease 9.6
950 glycogen storage disease 9.6
951 idiopathic interstitial pneumonia 9.6
952 nonspecific interstitial pneumonia 9.6
953 bruxism 9.6
954 severe acute respiratory syndrome 9.6
955 pulmonary tuberculosis 9.6
956 bursitis 9.6
957 cystic kidney disease 9.6
958 papillary carcinoma 9.6
959 cutis laxa 9.6
960 skin squamous cell carcinoma 9.6
961 tropical spastic paraparesis 9.6
962 lysosomal storage disease 9.6
963 demyelinating disease 9.6
964 myelitis 9.6
965 causalgia 9.6
966 lipid pneumonia 9.6
967 syringomyelia 9.6
968 central nervous system disease 9.6
969 bacterial vaginosis 9.6
970 palmoplantar keratosis 9.6
971 breast disease 9.6
972 plague 9.6
973 necrobiosis lipoidica 9.6
974 chronic wasting disease 9.6
975 superior mesenteric artery syndrome 9.6
976 olfactory neuroblastoma 9.6
977 leukorrhea 9.6
978 vaginal discharge 9.6
979 lung squamous cell carcinoma 9.6
980 thyroid gland follicular carcinoma 9.6
981 dentinogenesis imperfecta 9.6
982 intracranial thrombosis 9.6
983 hypertrichosis 9.6
984 carcinosarcoma 9.6
985 polyradiculoneuropathy 9.6
986 seminoma 9.6
987 macular retinal edema 9.6
988 bartter disease 9.6
989 pseudohypoaldosteronism 9.6
990 persian gulf syndrome 9.6
991 hypotrichosis 9.6
992 secretory meningioma 9.6
993 lymphoplasmacyte-rich meningioma 9.6
994 familial retinoblastoma 9.6
995 uremia 9.6
996 brain edema 9.6
997 calciphylaxis 9.6
998 aggressive systemic mastocytosis 9.6
999 movement disease 9.6
1000 eunuchism 9.6
1001 ovarian cyst 9.6
1002 chronic inflammatory demyelinating polyradiculoneuropathy 9.6
1003 eye disease 9.6
1004 adenosine deaminase deficiency 9.6
1005 hemolytic anemia 9.6
1006 brown-sequard syndrome 9.6
1007 acute stress disorder 9.6
1008 epithelioid sarcoma 9.6
1009 conjunctivitis 9.6
1010 reactive arthritis 9.6
1011 renal oncocytoma 9.6
1012 plasma cell neoplasm 9.6
1013 kummell's disease 9.6
1014 myositis ossificans 9.6
1015 mitochondrial metabolism disease 9.6
1016 premenstrual tension 9.6
1017 active peptic ulcer disease 9.6
1018 neuroblastoma 9.6
1019 childhood leukemia 9.6
1020 complement component 3 deficiency 9.6
1021 retinal degeneration 9.6
1022 dermatitis herpetiformis 9.6
1023 nervous system disease 9.6
1024 smallpox 9.6
1025 fascioliasis 9.6
1026 dermatophytosis 9.6
1027 viral infectious disease 9.6
1028 exophthalmos 9.6
1029 iridocyclitis 9.6
1030 acute myocardial infarction 9.6
1031 diabetes insipidus 9.6
1032 fasciitis 9.6
1033 necrotizing fasciitis 9.6
1034 pathologic nystagmus 9.6
1035 tenosynovitis 9.6
1036 radioulnar synostosis 9.6
1037 peripheral vertigo 9.6
1038 alopecia areata 9.6
1039 hypereosinophilic syndrome 9.6
1040 albinism 9.6
1041 myotonic dystrophy 9.6
1042 cleidocranial dysplasia spectrum disorder 9.6
1043 hypermobile ehlers-danlos syndrome 9.6
1044 isolated gonadotropin-releasing hormone deficiency 9.6
1045 mitochondrial disorders 9.6
1046 multiple epiphyseal dysplasia, recessive 9.6
1047 spondylocostal dysostosis, autosomal recessive 9.6
1048 allergic encephalomyelitis 9.6
1049 central congenital hypothyroidism 9.6
1050 chiari malformation 9.6
1051 chromosomal triplication 9.6
1052 chromosome 20p duplication 9.6
1053 dentinogenesis imperfecta type 2 9.6
1054 dwarfism 9.6
1055 epilepsy progressive myoclonic type 3 9.6
1056 germ cells tumors 9.6
1057 glossodynia 9.6
1058 heparin-induced thrombocytopenia 9.6
1059 homologous wasting disease 9.6
1060 htlv-1 associated myelopathy/tropical spastic paraparesis 9.6
1061 hyperadrenalism 9.6
1062 idiopathic neutropenia 9.6
1063 lathyrism 9.6
1064 lymphangiectasis 9.6
1065 medullary sponge kidney 9.6
1066 precocious puberty 9.6
1067 primary intestinal lymphangiectasia 9.6
1068 pure autonomic failure 9.6
1069 pustular psoriasis 9.6
1070 slc4a1-associated distal renal tubular acidosis 9.6
1071 spastic paraparesis 9.6
1072 sudden sensorineural hearing loss 9.6
1073 synovial chondromatosis 9.6
1074 thrombasthenia 9.6
1075 transverse myelitis 9.6
1076 raynaud phenomenon 9.6
1077 bunion 9.6
1078 cytomegalovirus infection 9.6
1079 dysautonomia 9.6
1080 headache 9.6
1081 posttransplant acute limbic encephalitis 9.6
1082 congenital hypogonadotropic hypogonadism 9.6
1083 cerebrofacial arteriovenous metameric syndrome 9.6
1084 familial calcium pyrophosphate deposition 9.6
1085 isolated bone marrow mastocytosis 9.6
1086 autosomal dominant epidermolytic ichthyosis 9.6
1087 autosomal recessive malignant osteopetrosis 9.6
1088 amelia 9.6
1089 eosinophilic colitis 9.6
1090 traumatic avascular necrosis 9.6
1091 idiopathic avascular necrosis 9.6
1092 erythema multiforme major 9.6
1093 autoimmune hypoparathyroidism 9.6
1094 acute liver failure 9.6
1095 moderate and severe traumatic brain injury 9.6
1096 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.6
1097 acute adrenal insufficiency 9.6
1098 laminopathy 9.6

Graphical network of the top 20 diseases related to Bone Mineral Density Quantitative Trait Locus 15:



Diseases related to Bone Mineral Density Quantitative Trait Locus 15

Symptoms & Phenotypes for Bone Mineral Density Quantitative Trait Locus 15

Human phenotypes related to Bone Mineral Density Quantitative Trait Locus 15:

31 (showing 1, show less)
# Description HPO Frequency HPO Source Accession
1 osteoporosis 31 HP:0000939

Symptoms via clinical synopsis from OMIM:

56
Skeletal:
osteoporosis
compression fractures (in homozygotes)
metaphyseal fractures (in homozygotes)

Clinical features from OMIM:

613418

UMLS symptoms related to Bone Mineral Density Quantitative Trait Locus 15:


tremor, back pain, angina pectoris, sciatica, equilibration disorder, muscle cramp, pelvic pain

Drugs & Therapeutics for Bone Mineral Density Quantitative Trait Locus 15

Drugs for Bone Mineral Density Quantitative Trait Locus 15 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 606, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Linagliptin Approved Phase 4 668270-12-0 10096344
2
Dinoprostone Approved Phase 4 363-24-6 5280360
3
Acetaminophen Approved Phase 4 103-90-2 1983
4
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
5
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
6
Teriparatide Approved, Investigational Phase 4 52232-67-4 16133850
7
Risedronate Approved, Investigational Phase 4 105462-24-6 5245
8
Esomeprazole Approved, Investigational Phase 4 161796-78-7, 119141-88-7, 161973-10-0 9568614 4594
9
Tibolone Approved, Investigational Phase 4 5630-53-5
10
Medroxyprogesterone acetate Approved, Investigational Phase 4 71-58-9
11
Atorvastatin Approved Phase 4 134523-00-5 60823
12
Etanercept Approved, Investigational Phase 4 185243-69-0
13
Pamidronate Approved Phase 4 40391-99-9 4674
14
Adalimumab Approved Phase 4 331731-18-1 16219006
15
Montelukast Approved Phase 4 158966-92-8 5281040
16
Lactitol Approved, Investigational Phase 4 585-88-6, 585-86-4 493591
17
Potassium citrate Approved, Investigational, Vet_approved Phase 4 866-84-2
18
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
19
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
20
Angiotensin II Approved, Investigational Phase 4 4474-91-3, 11128-99-7, 68521-88-0 172198
21
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
22
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
23
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
24
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
25
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
26
Gliclazide Approved Phase 4 21187-98-4 3475
27
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570
28
Basiliximab Approved, Investigational Phase 4 152923-56-3, 179045-86-4
29
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
30
Ritonavir Approved, Investigational Phase 4 155213-67-5 392622
31
Peginterferon alfa-2a Approved, Investigational Phase 4 198153-51-4 5360545
32
Ribavirin Approved Phase 4 36791-04-5 37542
33
Liraglutide Approved Phase 4 204656-20-2 44147092
34
Azathioprine Approved Phase 4 446-86-6 2265
35
Darunavir Approved Phase 4 206361-99-1, 635728-49-3 213039
36
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
37
Perindopril Approved Phase 4 107133-36-8, 82834-16-0 107807
38
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
39
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
40
Morphine Approved, Investigational Phase 4 57-27-2 5288826
41
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
42
Salmon calcitonin Approved, Investigational Phase 4 47931-85-1 16129616
43
Calcium carbonate Approved, Investigational Phase 4 471-34-1
44
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865